Singapore Health Sciences Authority Cracks Down on E-Cigarette Black Market

Jul.05.2024
Singapore Health Sciences Authority Cracks Down on E-Cigarette Black Market
Singapore Health Sciences Authority (HSA) seized over 350,000 e-cigarette products worth $6 million in June raids.

According to Channel News Asia's report on July 4th, the Health Sciences Authority (HSA) in Singapore stated that over 350,000 e-cigarette products were seized in raids across the country in June.


The black market value of these e-cigarette products exceeds 6 million Singapore dollars (approximately 4.44 million US dollars) and were originally planned to be sold through Telegram.


The Health Sciences Authority (HSA) confirmed that a series of raids carried out from June 14 to 18 at three separate locations effectively targeted one of Singapore's largest e-cigarette distribution networks.


Authorities received news on June 14 that a large quantity of e-cigarettes and components were found in a warehouse at Woodlands Loop.


Following that, there were two more raids conducted, one at an apartment unit on Guillemard Crescent on the same day, and another at a warehouse unit in the Woodlands industrial park on June 18th. HSA stated that more e-cigarette products were also found at these two locations.


Additionally, 14 e-cigarettes suspected to contain the controlled substance tetrahydrocannabinol (THC) have been discovered, and these products have been handed over to the Central Narcotics Bureau (CNB) for processing. Four men and women, ranging in age from 34 to 52, are currently assisting in the investigations conducted by the Health Sciences Authority (HSA) and CNB.


The Health Sciences Authority (HSA) has reported seizures of e-cigarette products worth over 18 million Singapore dollars (13.32 million US dollars) since January. Authorities have warned that importing, distributing, selling, or advertising e-cigarette products is illegal.


For the first time offenders found importing, distributing, or selling e-cigarette products, they can be fined up to $10,000 (USD 7401), or face imprisonment for a maximum of 6 months, or both. For second-time offenders and beyond, the maximum fine can reach $20,000 (USD 14,802), or imprisonment for up to 12 months, or both. It is illegal to purchase, use, or possess e-cigarettes, with a maximum fine of $2000 (USD 1480).


Last year, Singapore authorities dealt with around 8,000 cases of e-cigarette-related offenses, a 43% increase from the 5,600 cases in 2022. There were a total of 7,600 recorded offenses in 2021.


In December of last year, authorities announced plans to enhance inspections of e-cigarettes and their components at border checkpoints in Singapore. They also stated that they would increase efforts to combat the use of e-cigarettes in "public hotspots.


From January 1 to March 31, it was discovered that over 2200 people were using or in possession of e-cigarettes.


In May this year, Rahayu Mahzam, the Senior Parliamentary Secretary of the Ministry of Health, stated that the Health Sciences Authority is reviewing legal penalties to enhance deterrence against e-cigarette advertising, importation, and distribution.


She added that the Health and Safety Authority has been monitoring illegal e-cigarette sales on social media, e-commerce, and communication platforms, and taking action to remove e-cigarette-related content.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Special Report | From New York to Washington: How FDA’s Tobacco Center Is Reworking Product Review
Special Report | From New York to Washington: How FDA’s Tobacco Center Is Reworking Product Review
FDA’s Center for Tobacco Products is reshaping how it approaches tobacco product review. Based on 2Firsts’ on-site reporting in New York and Washington, this report traces CTP’s emerging direction: stronger links between PMTA and tobacco harm reduction, more category-specific review, greater emphasis on decision-relevant science, more predictable timelines and expanded use of sPMTA for product modifications. CTP also acknowledged major constraints, including just nine PMTA review teams, persistent backlogs and limits on hiring capacity.
Regulations
Oct.08
Altria Showcases Ploom, Marlboro Heated Tobacco Sticks and Non-Nicotine Energy Products at NACS Show 2026
Altria Showcases Ploom, Marlboro Heated Tobacco Sticks and Non-Nicotine Energy Products at NACS Show 2026
At the 2026 NACS Show, Altria displayed Ploom devices alongside imagery of Marlboro-branded heated tobacco sticks, while also featuring RIOT Energy and Proper Wild non-nicotine products. The booth showcased on! PLUS nicotine pouches, including 12 mg variants not listed among FDA-authorized products as of October 9, and NJOY e-cigarettes. Altria also presented convenience-store traffic figures highlighting its retail presence. 2Firsts examines the company's expanded product portfolio, non-nicotine business activities and the regulatory status of products displayed at the show.
EXPO
Oct.10
Japan Survey Finds 49.5% Would Cut Tobacco Use if Prices Rise, 64.6% Show Interest in Nicotine-Free Alternatives
Japan Survey Finds 49.5% Would Cut Tobacco Use if Prices Rise, 64.6% Show Interest in Nicotine-Free Alternatives
A September online survey commissioned by Japanese smoking-accessories company Lightec found that 49.5% of respondents would consider reducing tobacco use if prices rose further, while 25.1% would consider switching to cheaper brands and 14.5% would consider using or combining alternatives such as vapes and nicotine-free herbal sticks. Another 64.6% expressed some level of interest in such alternatives. The survey covered 1,088 respondents aged 20 to 70 and was conducted by a company that sells NICOLESS nicotine-free vaping and herbal-stick products, meaning its findings should not be treated as representative of Japan's smoking population.
DATA
Oct.12
Russia’s Vape Device Labeling Regime Enters Force: Registration Starts in September, Mandatory Coding in December
Russia’s Vape Device Labeling Regime Enters Force: Registration Starts in September, Mandatory Coding in December
Russia's digital labeling regime for reusable e-cigarettes and similar personal vaping devices entered its first mandatory phase in September 2026. From September 1, manufacturers, importers and other market participants must register with the national Chestny ZNAK tracking system. From December 1, newly manufactured and imported covered devices will be required to carry digital identification codes and be reported as entering circulation. Russia has also issued new operational guidance for imports, marking the transition from a voluntary pilot to phased mandatory implementation.
Sep.15
Ispire Q4 Revenue Rebounds 33% but Full-Year Sales Still Fall 25% as FY2027 Focus Shifts to Malaysia Manufacturing, ODM, Nicotine Pouches and Age Verification
Ispire Q4 Revenue Rebounds 33% but Full-Year Sales Still Fall 25% as FY2027 Focus Shifts to Malaysia Manufacturing, ODM, Nicotine Pouches and Age Verification
Ispire Technology reported FY2026 revenue of about $96 million, down 24.7% year over year, as U.S. cannabis-vapor hardware and European e-cigarette sales declined by $17.4 million and $12.7 million, respectively. Fourth-quarter revenue rose 32.5% to $26.7 million, while quarterly gross margin fell to 6.3%. For FY2027, the company is prioritizing Malaysia manufacturing and vapor ODM while continuing to develop nicotine pouches, IKE Tech age-verification technology and G-Mesh licensing. Ispire has not separately disclosed the revenue or profit contribution of those newer businesses.
Regulations
Sep.17 by 2Firsts Perspectives
Wall Street Journal: U.S. FDA Plans Faster Vape and Nicotine Pouch Reviews, Revisit of 2021 PMTA Rule
Wall Street Journal: U.S. FDA Plans Faster Vape and Nicotine Pouch Reviews, Revisit of 2021 PMTA Rule
The Trump administration is preparing changes intended to accelerate FDA market authorization reviews for e-cigarettes and nicotine pouches, according to The Wall Street Journal. The FDA is expected to revisit its 2021 PMTA rule and may simplify some scientific study requirements and shorten review times. The agency has not formally announced the changes. Over the past year, the FDA has already accelerated nicotine-pouch reviews, expanded ENDS authorizations and upgraded its CTP Portal NextGen application system. As of August 2026, 43 nicotine pouch products and 48 e-cigarette products had received FDA marketing authorization.
Sep.24